Financial Data and Key Metrics Changes - Revenue increased by 54% year-over-year, reaching R$274 million in Q2 2020, with a net revenue increase of 48.8% year-over-year [10][23] - Adjusted EBITDA rose 73% to R$180 million, with a margin expansion of 780 basis points [23][24] - Adjusted net income increased by 163%, with earnings per share rising 183% from R$0.23 to R$0.65 [24] Business Line Data and Key Metrics Changes - Medical school seats increased by 414 year-over-year, totaling 1,516 seats, a 38% increase [22] - The number of students rose by 64% year-over-year, reaching 9,097 [22] - In BU2, active paying students increased by 47%, with significant growth in both prep courses and continuing medical education [25] Market Data and Key Metrics Changes - The company maintained 100% occupancy for medical seats during the quarter, allowing for consistent pricing strategies [10] - Monthly active users for digital platforms increased by 27.6% compared to Q1 2020 [14] Company Strategy and Development Direction - The company aims to enhance its digital capabilities and integrate digital health services, exemplified by the acquisition of PEBMED [12][13] - Strategic M&A remains a key pillar of growth, with six acquisitions completed post-IPO and a strong pipeline for future opportunities [15][18] - The focus is on maintaining a healthy balance sheet while pursuing sustainable and predictable growth [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's resilience and ability to exceed financial targets despite the challenges posed by COVID-19 [19][31] - The company anticipates strong demand for medical seats and expects to recognize deferred revenues from practical classes in the second half of 2020 [30] Other Important Information - The company has over R$1 billion in cash, with a cash flow generation rate of 83% EBITDA to cash [11] - The integration of acquired companies is ongoing, with significant synergies still to be captured [11][17] Q&A Session Summary Question: Plans for BU2 and monetization strategy - Management indicated that BU2 will focus on integrating digital platforms and enhancing user experience, with plans to launch an integrated app for students [34] Question: M&A competition and pricing - Management acknowledged increased competition in M&A but emphasized a disciplined approach to acquisitions, targeting mature institutions with favorable EBITDA multiples [36][37] Question: Margin evolution and acquisition integration - Management noted that there is still significant room for margin improvement from recent acquisitions, with expectations of capturing more synergies [44] Question: Partnerships and potential acquisitions - Management clarified that they have around 40 medical institutions using their platform, which could facilitate future acquisitions [50] Question: PEBMED's cross-selling potential - Management confirmed that while PEBMED primarily targets medical students, there are opportunities to expand into other healthcare careers [52]

Afya Limited (NASDAQ:AFYA) Q1 2020 Earnings Conference Call May 29, 2020 11:00 AM ET Company Participants Renata Couto - Head of Investor Relations Virgilio Deloy Capobianco Gibbon - Chief Executive Officer Júlio Eduardo Razente de Angeli - Vice President of Continuing Education and Innovation Luis André Blanco - Chief Financial Officer Conference Call Participants Marcelo Santos - J.P. Morgan Susana Salaru - Itau BBA Vinicius Ribeiro - UBS Irma Sgarz - Goldman Sachs Scott Piper - Itau Securities Operator G ...

As filed with the Securities and Exchange Commission on April 20, 2020. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ¨ SHELL COMPANY REPORT PURSUAN ...

Afya Limited (NASDAQ:AFYA) Q4 2019 Earnings Conference Call March 27, 2020 11:00 AM ET Company Participants Renata Couto - Head of Investor Relations Virgilio Gibbon - Chief Executive Officer Luciano Campos - Chief Financial Officer Luis André Blanco - Chief Financial Officer-elect Júlio Angeli - Vice President of Continuing Education and Innovation Conference Call Participants Marcelo Santos - JPMorgan Chase & Co. Susana Salaru - Itaú Corretora de Valores S.A. Vinicius Ribeiro - UBS Investment Bank Irma Sg ...

Afya Limited (NASDAQ:AFYA) Q3 2019 Results Earnings Conference Call December 2, 2019 11:00 AM ET Company Participants Renata Couto - IR Virgilio Gibbon - CEO Luciano Campos - CFO Conference Call Participants Thiago Bortoluci - Goldman Sachs Susana Salaru - ITAU Operator Good morning, ladies and gentlemen, and welcome to the Afya Third Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will foll ...